New Zealand markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
111.29+0.65 (+0.59%)
At close: 04:00PM EDT
112.07 +0.78 (+0.70%)
After hours: 07:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.90B
Enterprise value 28.46B
Trailing P/E 24.14
Forward P/E 13.79
PEG ratio (5-yr expected) 1.67
Price/sales (ttm)3.12
Price/book (mrq)1.82
Enterprise value/revenue 3.82
Enterprise value/EBITDA 13.19

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-19.44%
S&P500 52-week change 318.96%
52-week high 3139.31
52-week low 3102.00
50-day moving average 3111.09
200-day moving average 3117.38

Share statistics

Avg vol (3-month) 31.55M
Avg vol (10-day) 31.53M
Shares outstanding 5205.73M
Implied shares outstanding 6205.73M
Float 8205.24M
% held by insiders 10.12%
% held by institutions 191.93%
Shares short (15 Jul 2024) 45.82M
Short ratio (15 Jul 2024) 43.4
Short % of float (15 Jul 2024) 43.20%
Short % of shares outstanding (15 Jul 2024) 42.83%
Shares short (prior month 14 Jun 2024) 44.63M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.86%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.87%
5-year average dividend yield 40.74
Payout ratio 420.82%
Dividend date 331 Jul 2024
Ex-dividend date 426 Jun 2024
Last split factor 2103:100
Last split date 301 Mar 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.93%
Operating margin (ttm)20.78%

Management effectiveness

Return on assets (ttm)4.43%
Return on equity (ttm)7.80%

Income statement

Revenue (ttm)7.45B
Revenue per share (ttm)35.89
Quarterly revenue growth (yoy)3.20%
Gross profit (ttm)N/A
EBITDA 2.47B
Net income avi to common (ttm)963.9M
Diluted EPS (ttm)4.61
Quarterly earnings growth (yoy)-25.90%

Balance sheet

Total cash (mrq)393M
Total cash per share (mrq)1.91
Total debt (mrq)6B
Total debt/equity (mrq)47.63%
Current ratio (mrq)1.66
Book value per share (mrq)61.24

Cash flow statement

Operating cash flow (ttm)1.5B
Levered free cash flow (ttm)1.07B